Checkpoint Inhibitors in SCLC: How Much Can We Trust in Randomized Cohorts of Phase I/II Trials?

Jessica Menis, Martin Reck

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish
Pages (from-to)308-310
Number of pages3
JournalJournal of Thoracic Oncology
Volume15
Issue number3
DOIs
Publication statusPublished - Mar 2020

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine

Cite this